ABCD4 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.799000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.977600E-01
Normal-vs-Stage2
2.633600E-01
Normal-vs-Stage3
6.080400E-02
Normal-vs-Stage4
4.522000E-01
Stage1-vs-Stage2
9.735600E-01
Stage1-vs-Stage3
1.879800E-01
Stage1-vs-Stage4
5.992800E-01
Stage2-vs-Stage3
1.067380E-01
Stage2-vs-Stage4
5.638200E-01
Stage3-vs-Stage4
8.975900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.911600E-01
Normal-vs-AfricanAmerican
3.049700E-02
Normal-vs-Asian
4.584800E-01
Caucasian-vs-AfricanAmerican
1.350640E-01
Caucasian-vs-Asian
8.575600E-01
AfricanAmerican-vs-Asian
2.255600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.405200E-01
Normal-vs-Female
2.143000E-01
Male-vs-Female
7.184200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.684000E-01
Normal-vs-Age(41-60Yrs)
3.823800E-01
Normal-vs-Age(61-80Yrs)
2.308600E-01
Normal-vs-Age(81-100Yrs)
2.965200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.065200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.466000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.478200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.694810E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.676600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.259750E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.257590E-01
Normal-vs-Daily Drinker
6.338800E-01
Normal-vs-Weekly Drinker
2.529400E-01
Normal-vs-Occasional Drinker
6.483000E-01
Normal-vs-Social Drinker
3.194400E-01
Non Drinker-vs-Daily Drinker
1.391610E-01
Non Drinker-vs-Weekly Drinker
7.335000E-01
Non Drinker-vs-Occasional Drinker
4.523800E-02
Non Drinker-vs-Social Drinker
2.484200E-01
Daily Drinker-vs-Weekly Drinker
3.893000E-01
Daily Drinker-vs-Occasional Drinker
7.762200E-01
Daily Drinker-vs-Social Drinker
7.166600E-01
Weekly Drinker-vs-Occasional Drinker
1.962240E-01
Weekly Drinker-vs-Social Drinker
5.262200E-01
Occasional Drinker-vs-Social Drinker
4.419200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.255200E-01
Normal-vs-Grade 2
7.324000E-01
Normal-vs-Grade 3
7.149600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.586200E-01
Grade 1-vs-Grade 3
7.097800E-01
Grade 1-vs-Grade 4
4.255200E-01
Grade 2-vs-Grade 3
7.304600E-01
Grade 2-vs-Grade 4
7.324000E-01
Grade 3-vs-Grade 4
7.149600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.191600E-01
Normal-vs-NonDiabetic
3.550000E-01
Diabetic-vs-NonDiabetic
3.959000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.791220E-01
Normal-vs-NoPancreatitis
2.711000E-01
Pancreatitis-vs-NoPancreatitis
5.553600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.608000E-01
Normal-vs-N1
2.714600E-01
N0-vs-N1
9.485200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.713000E-01
Normal-vs-TP53-NonMutant
4.304800E-01
TP53-Mutant-vs-TP53-NonMutant
8.110000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
